Ultralife shareholders elect all five directors, ratify auditor at 2022 annual meeting

ULTRALIFE CORP

All five director nominees elected with majority support; Ranjit C. Singh received 9.8M for vs 1.6M withheld.
Ratification of Freed Maxick CPAs as independent auditor approved: 13.66M for vs 15.8K against.
Quorum of 85% of outstanding shares (13.7M of 16.1M) present at July 20, 2022 meeting.
Directors elected to one-year terms until 2023 annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.